CLINICAL_TRIALS
trial_result
· 2023-09-29
Clinical Trial Update: Study of BHV-3241 in Participants With Multiple System Atrophy [Phase 3]
Summary
Phase 3 trial of BHV-3241 in participants with Multiple System Atrophy has completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: Multiple System Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2023-09-29